JPRN-UMIN000022989
Completed
未知
Comparative study of once vs. twice daily regimen of double dose of rabeprazole in uncontrolled GERD patients taking usual dose of proton pump inhibitors. - Once vs. twice daily regimen of double dose PPI in GERD
Keiyu Hospital Internal Medicine0 sites100 target enrollmentJuly 2, 2016
ConditionsGastro-Esophageal Reflux Disease
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Gastro-Esophageal Reflux Disease
- Sponsor
- Keiyu Hospital Internal Medicine
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Subjects who have any mental disorders Subjects who have histories of allergy against laperazol Subjects who have serious complications and problems to continue to perform this clinical trial Subjects who are pregnant, possibly pregnant, or feeding her children Subjects who cannot accept an upper GI endoscopic examination Subjects who have two\-fold dose of PPI during 4 weeks before the clinical trial starts Subjects who are decided to be unacceptable for this clinical trial by their clinical physicians
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
Glargine once versus twice dailyCTRI/2023/10/059275surbhi bharti
Completed
Phase 2
Comparison of the effect of single and twice daily administration of ranitidine in relief of morning abdominal pain and nausea in childreabdominal pain and nausea.Unspecified abdominal painIRCT20171211037830N2Deputy of Research of Golestan University of Medical Sciences150
Active, not recruiting
Not Applicable
Effects and comparisons of once & twice daily insulin’s in combination with oral hypoglycaemic agents on glycaemic control, hypoglycaemia and weight in type 2 Diabetes.Type 2 DiabetesMedDRA version: 8.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2005-003824-21-GBRoyal Liverpool University Hospital
Completed
Phase 4
Once-Daily Asenapine for SchizophreniaSchizophreniaNCT01549041Duke University30
Completed
Phase 4
Efficacy of once daily versus divided daily administration of low daily dosage (15 mg/day) of methimazole in the induction of euthyroidism in Graves' hyperthyroidism: A randomized controlled studyGraves’ hyperthyroidismGraves’ hyperthyroidism,once daily methimazole administration,induction of euthyroidismTCTR20170529001one55